| | SUMMER COURSE "CELLULAR BIOLOGY OF ADDICTION" Partnered with the CSHL July 19 - July 25, 2012
Application Deadline: March 15, 2012 Instructors:
Rafael Maldonado, Universitat Pompeu Fabra
Brigitte L. Kieffer, CERBM/University of Strasbourg
Chris Evans, University of California, Los Angeles, USA
Antonello Bonci, National Institute on Drug Abuse-NIDA, Baltimore, USA
The primary objective of the workshop is to provide an intense discussion of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction.
Targeted to both new and experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research.
The workshop will stress the significance of this approach not only to the most costly neuropsychiatric disorder, addiction, but its applicability to learning, memory, neurochemical correlates of reward, perception and other disciplines of neuroscience. Research on the molecular and cellular changes that occur in response to drugs is critical for clarifying whether adaptive processes are diverse for each stage of addiction and for each drug of abuse. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, craving, and relapse to drug use. The workshop will provide attendees with a spectrum of disciplines that can contribute to developing comprehensive models of each stage of drug addiction. The following disciplines will be presented: 1.Overview of addiction.
2. Neuroadaptation to drugs of abuse.
3. Association between drug-induced neuroadaptation and behavioral manifestations
4. Genotype/susceptibility to drug addiction or drug response
5. Tolerance, sensitization and adaptation at the cellular level
6. New receptor targets.
7. Drug discovery and development to treat drug abuse: how can cell biology contribute? This workshop will provide an integrated view of current and novel research on neuroadaptive responses to addiction, foster discussion on collaboration and integration and provide critical information needed to construct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond the plane of scientific endeavour, such information is vital for formulating public policy and for enlightening the public on the neurobiological consequences of drug use and addiction. The proposed workshop will generate intense interest, open conduits for collaborations and novel routes to investigating the neurobiology of addiction. The workshop makes particular efforts to include a diverse group of participants, being particularly mindful of the inclusion of women and a good balance of European and North American scientists.
Confirmed speakers
David Belin (University of Poitiers, Poitiers, France)
Antonello Bonci (National Institute on Drug Abuse, Baltimore, USA)
Carmen Cavada (Universidad Autónoma de Madrid, Madrid, Spain)
Charles Chavkin (University of Washington, Seattle, USA)
Chris Evans (University of California, Los Angeles, USA)
David Goldman (Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, USA)
Markus Heilig (NIAA, Rockville, USA and Faculty of Health Sciences, Linköping University, Linköping, Sweden)
Istvan Katona (Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary)
Brigitte L. Kieffer (CERBM and University of Strasburg, Illkirch, France)
George F. Koob and Barbara Mason (Scripps Institute, La Jolla, USA)
Mary-Jean Kreek (Rockeffeler University, New York, USA)
Evgeny Krupitsky (AV Valdman Institute of Pharmacology, St. Petersburg State I. P.Pavlov Medical University, St. Petersburg, Russia)
Angus C. Nairn (Yale University, New Haven, USA)
Richard Palmiter (Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, USA)
Marina Picciotto (Yale University, New Haven, USA)
Jonathan Pollock (National Institute on Drug Abuse, Bethesda, USA)
Rafael Maldonado (Neurophar, University Pompeu Fabra, Barcelona, Spain)
Vladimir de Semir (Universitat Pompeu Fabra, Barcelona, Spain)
Rainer Spanagel (Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany)
Kari Stefansson (DeCode Genetics, Reykjavik, Iceland)
Pier Vincenzo Piazza (NeuroCenter François Magendie, INSERM, Bordeaux, France)
Nora D. Volkow (National Institute on Drug Abuse, Bethesda, USA)
Taco de Vries (VU University Medical Center, Amsterdam, The Netherlands)
Ilana Witten (Stanford University, Stanford, USA)
Andreas Zimmer (University of Bonn, Germany) The course will be held at the PRBB (Barcelona Biomedical Research Park) excellently located at Barcelona's seafront. The course is supported with funds provided by the National Institute of Drug Abuse and the Federation of European Neuroscience Societies . Scholarships funds are available for partial support of tuition, room and board on a merit basis. Partial support from the Spanish (MINECO) and the Catalan (AGAUR) Governments is also acknowledged. Cost (including board and lodging): 1,500 € (This cost will be reduced by the scholarship program on an individual basis). Currency converter Click here for more information and way to register for the course http://www.suportserveis.cat/CSHLSummerCourse/ | |
No comments:
Post a Comment